Jama Editors' Summary: On Research In Medicine, Science, & Clinical Practice. For Physicians, Researchers, & Clinicians.

Pamrevlumab for IPF, Dapagliflozin in Critical Illness, Payer Involvement in Evidence Generation, and more

Informações:

Synopsis

Editor’s Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the August 6, 2024, issue.